Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED | N.MMED.WA | N.MMED.WR | N.MMED.WS

Healthcare
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:MNMD)

MindMed to Participate in June Conferences

Business Wire 10 days ago

MindMed to Participate at May Investor Conferences

Business Wire May 9, 2024

New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US

Business Wire May 9, 2024

MindMed Reports First Quarter 2024 Financial Results and Business Updates

Business Wire May 8, 2024

MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York

Business Wire May 4, 2024

MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update

Business Wire May 2, 2024

MindMed to Present at Upcoming May Medical Conferences

Business Wire April 25, 2024

MindMed to Present at Upcoming April Medical Conferences

Business Wire April 2, 2024

MindMed Announces Voluntary Delisting from Cboe Canada

Business Wire April 1, 2024
View More News ››

Opinion & Analysis (NDAQ:MNMD)

Buzz on the Bullboards: Tracking the Big Movers of 2020

Stockhouse Editorial December 17, 2020

Broadway Gold ramps up exploration at Madison Mine

The Gold Report March 2, 2017
View More Opinion ››

Bullboard Posts (NDAQ:MNMD)

RE:RE:RE:Stock Price Pressure

49.12% % of Shares Held by Institutions 50.47% % of Float Held by Institutions 161 Number of Institutions Holding Shares % was 5%,...
Robert1999 - 1 day ago

RE:Stock Price Pressure

This doesn't look great. PTSD treatment was kind of MM's thing. https://www.forbes.com/sites/roberthart/2024/06/05/psychedelic...
Starkicker - 1 day ago

RE:RE:Stock Price Pressure

Further searching found this on seeking alpha https://seekingalpha.com/news/4113189-rbc-recommends-buying-mindmed-amid-psychedelic-stocks...
sollmg - 2 days ago

RE:Stock Price Pressure

100% agree It's not the time to sell
Robert1999 - 2 days ago

Stock Price Pressure

I looked for news to try and find a reason for the price movement. Found nothing bad. Then looked at the shorts. 22% of the float short...
sollmg - 2 days ago

RE:mmed

You might have to call your broker to request a transfer to NSDQ otjerwise the shares will show up in your account but the values won'...
Starkicker - April 12, 2024
View more Bullboard ››

Lahontan Gold Corp.

Lahontan Gold Corp.

Lahontan Gold Corp. is a Canada-based mineral exploration company. The Company is engaged in the identification, acquisition, ...
View More »